AimingMed is a leading biotech company specializing in organoid technology. Our techniques empower clinicians with organoid-based drug sensitivity tests, facilitating the selection of the most suitable treatment options for patients. Moreover, we offer organoid-based disease models with high-throughput capability to biopharma and biotech companies, accelerating drug development at lower costs. With our innovative platform, we strive to advance precision medicine and expedite drug development.
We are committed to our mission — “Give Directions for Heal, Bring Hopes for Life”.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.

The ARC Training Centre for Cell and Tissue Engineering Technologies (CTET) is a world-class research and training initiative, established to advance regenerative medicine and tissue engineering. A collaboration between Monash University, Queensland University of Technology, and industry partners, the Centre focuses on developing innovative solutions to address critical health challenges while equipping the next generation of researchers with industry-ready skills. CTET’s research drives technological breakthroughs, creates industry impact, and delivers transformative health outcomes for the community.

About Materialise
Materialise incorporates 30 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the largest and most complete 3D printing facilities in the world.

In a world where one size fits no one, everyone deserves truly individual care. Materialise supports researchers, engineers, and healthcare professionals in developing and scaling personalized treatments that have improved and saved the lives of more than six million patients. Through a range of products and services — including Mimics Innovation Suite, 3D-printed surgical guides and implants, and clinical engineering services — Materialise accelerates mass personalization in healthcare.

For more information on how Materialise supports personalized and sustainable patient care, please visit https://www.materialise.com/en/healthcare.

Biointerphases emphasizes quantitative characterization of biomaterials and biological interfaces. As an interdisciplinary journal, a strong foundation of chemistry, physics, biology, engineering, theory, and/or modelling is incorporated into originated articles, reviews, tutorials, and opinionated essays. In addition to regular submissions, the journal regularly features Special Topic Collections, targeted on specific topics and edited by experts in the field.

The Graeme Clark Institute (GCI) for Biomedical Engineering was created in 2017 to coordinate biomedical engineering activities across the University of Melbourne. We are dedicated to transforming healthcare with biomedical engineering solutions that deliver global health, societal and economic benefits.

Company Name: Immersive Science LLC

Website: www.immsci.com

About Us:
Immersive Science LLC develops cutting-edge virtual reality (VR) tools tailored to support research scientists. Our applications enable intuitive visualization and exploration of complex datasets, providing researchers with powerful insights and a new dimension of understanding.

Mission:
To empower research scientists with immersive visualization tools that enhance data exploration, foster collaboration, and accelerate scientific discovery.

Products and Services:

ConfocalVR: Advanced tools for 3D/4D visualization of confocal image stacks.
StarGateVR: Interactive VR-based tools for analyzing astronomical data.
FlowGateVR: Immersive exploration of flow cytometry datasets.
Custom VR application development for research institutions.
Contact Information:

Email: tskillman@immsci.com
Phone: 206-349-0907
Address: 6835 113th Pl SE, Newcastle, WA 98056, USA

Local contact in Australia
Carmine Onofrillo, Phd,
Research fellow
The University of Melbourne, Department of Surgery
carmine.onofrillo@unimelb.edu.au

The South Australian node of ANFF-SA offers access to more than $10 million of equipment and technical excellence in design, fabrication, and testing of micro-scale devices. The facility’s strengths include lab-on-a-chip technology, micro/nanofluidics, advanced sensing, functional coatings, and separation science.

ANFF-SA houses state-of-the-art photolithography, micromachining, hot embossing and bonding, micro-injection moulding, plasma etching, thin film coating, fluidic simulation, and advanced characterisation in ISO Class 5 & 6 clean room environments.

Co-located at the University of South Australia and Flinders University, ANFF-SA offers extensive materials and surface spectroscopy capabilities and, where research or process development is required, ANFF-SA can facilitate scientific expertise locally or arrange access to ANFF sites at 17 other universities around Australia.

ANFF-SA’s facilities are open to industry and academic users and surface structures and patterns, channel designs, and chemical functionality can be tailored to your needs, through access or partnership with ANFF-SA’s technical staff.

Our professional technical staff are experienced working with confidential information and sensitive project material and able to deliver high-quality devices and samples on time and within budget.

The South Australian node offers capabilities, expertise, and opportunities to collaborate with affiliated staff in the fields of:

• Micro/nanofluidics

• Surface chemistry

• Surface structuring (etching, molding, embossing)

• Thin film deposition

• Surface spectroscopy

• X-ray micro/nanotomography (volumetric analysis)

ANFF-SA offers professional training on cutting-edge equipment housed in world-class facilities to enable you to develop your ideas, create prototypes and characterise the outcomes or you can engage our expertise to perform research on your behalf.

Either way, ANFF-SA can elevate your research and development to the next level, with better designs, shorter development iteration cycles, and expert training and advice.

Contact Facility Manager ANFF-SA@unisa.edu.au​ or +61 8 8302 5226 today to find out how ANFF-SA can support your next project or to arrange a tour of our facilities.

The ARC Industrial Transformation Training Centre for Joint Biomechanics is a leading research Centre dedicated to advancing joint biomechanics. We bring together top researchers, industry partners, and end-users to train a skilled, multidisciplinary workforce. Our focus includes bio-engineered tissue scaffolds, with a commitment to training and development. We aim to transform orthopaedic surgery through innovative biomechanical modelling and simulation platforms. Our work spans three Australian universities and numerous international partners, driving superior personalised patient care and fostering the next generation of experts in joint biomechanics.

ANFF-Qld is part of the Australian National Fabrication Facility (ANFF), a not-for-profit research infrastructure network established under the National Collaborative Research Infrastructure Strategy (NCRIS). ANFF operates across 8 nodes throughout Australia, supported by over $200 million in investments in cutting-edge equipment, state-of-the-art infrastructure, and a team of highly skilled experts.
The Australian National Fabrication Facility’s Queensland Node (ANFF-Qld) is a premier micro- and nanofabrication hub, providing access to state-of-the-art equipment and expert support. Our specialist areas include microfluidics, organic electronics, biomaterials, novel semiconductor materials, and advanced characterisation techniques.
ANFF-Qld has facilities within the Australian Institute for Bioengineering and Nanotechnology (AIBN) and the Centre for Organic Photonics & Electronics (COPE) at The University of Queensland, as well as within the Queensland Micro- and Nanotechnology Centre (QMNC) and the Queensland Microtechnology Facility (QMF) at Griffith University. Additionally, ANFF-Qld offers access to ANFF sites at 17 other leading universities across Australia.
ANFF-Qld provides access to world-class facilities and professional training, enabling you to bring your ideas to life, develop prototypes, and characterise your innovations. Whether you choose to access our facilities directly or engage our skilled staff to conduct research on your behalf, ANFF-Qld is here to support your R&D needs. With cutting-edge technology, streamlined development cycles, and expert guidance, ANFF-Qld can help elevate your research and product development to new heights.
Contact us:
Website: https://anff-qld.org.au/
Email: anff@uq.edu.au

AimingMed is a leading biotech company specializing in organoid technology. Our techniques empower clinicians with organoid-based drug sensitivity tests, facilitating the selection of the most suitable treatment options for patients. Moreover, we offer organoid-based disease models with high-throughput capability to biopharma and biotech companies, accelerating drug development at lower costs. With our innovative platform, we strive to advance precision medicine and expedite drug development.
We are committed to our mission — “Give Directions for Heal, Bring Hopes for Life”.

ATA SCIENTIFIC: TODAY’S INSTRUMENTS. TOMORROW’S INSIGHTS

ATA Scientific specialises in sales, support and service for a range of advanced analytical instruments in the areas of Particle, Material and Biomolecular Science and SEM imaging. Our growing range of technologies are suitable for the characterisation of nanoparticles, proteins and other biological molecules used in the development of biomaterials and tissue engineering including biointerfaces, biopolymers, implants, drug delivery, nanomedicines, scaffolds, cell therapies and more.
Our systems provide access to a raft of biophysical information to enable rapid formulation development and increased efficiency for quality control and manufacturing processes.
The result is a toolbox of complementary systems that support today’s diverse characterisation needs.
Some of our latest instruments include:
• RedShiftBio Aurora uses Microfluidic Modulation Spectroscopy (MMS) – one of the only techniques which can directly monitor the formation of aggregates due to its ability to measure intermolecular beta-sheet structures.
• Malvern OMNISEC multi detection Size Exclusion Chromatography (SEC) detectors provide a wealth of additional information to assess protein aggregates and determine protein structure and functional activity.
• Malvern NanoSight Pro uses nanoparticle tracking to quantify early aggregation in bioformulations.
• Malvern PEAQ ITC to accurately determine binding parameters to understand molecular interactions.
• Malvern Zetasizer Ultra for particle and molecular size, particle charge and particle concentration.
• Phenom Desktop Scanning Electron Microscope (SEM) with X-ray analysis (EDS) for element ID.
• KRUSS Drop shape analysers integrate a high level of automation to simplify surface measurements.
Enquire today…
For further details contact
ATA Scientific Pty Ltd
+61 2 9541 3535
enquiries@atascientific.com.au
www.atascientific.com.au

Eppendorf – You have a vision. We have a mission.

At Eppendorf, our aim is to empower you on your upstream bioprocess journey. We provide trusted and innovative bioprocess solutions to develop cell culture and fermentation bioprocesses and move them from R&D to production. We have orchestrated our scalable bioprocess systems, single-use bioreactors, software solutions, and services to optimize process control, automate routine tasks, and harness the power of data. We listen to your specific challenges and work together with you to solve them. The bottom line is more speed, less risk, and more success in your business.

Our purpose is to help bring life-saving treatments to the world. With our bioprocess solutions and in line with our corporate mission, we contribute to the efforts of Eppendorf customers worldwide to improve human living conditions.

Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide.

Microscopy Australia

Microscopy Australia provides researchers and industry with access to the nation’s largest range of high-end microscopes, microanalysis tools, and specialists. It consists of university-based microscopy centres around the country.

Our open access policy means that researchers anywhere in Australia can access any of our nine university-based facilities and a range of other linked microscopy labs. Our instruments have dedicated experts to deliver high quality training and support to ensure you get the best research outcomes.

Pawsey

The Pawsey Supercomputing Research Centre is one of two Tier-1 High-Performance Computing facilities in Australia. Its primary function is to accelerate scientific research for the benefit of the nation. Our service and expertise in supercomputing, data, cloud services and visualisation, enables research across a spread of domains including astronomy, life sciences, medicine, energy, resources and artificial intelligence. Data is stored close to supercomputers, allowing seamless analysis. The adjacent, remote rendering capability allows real-time visualisation of simulations and data.

We support students, industry personnel, researchers, academics, and scientists through seminars and symposia on data, visualisation, and supercomputing, as well as training, internships, and workshops on advanced computing and research and development opportunities.

Spatial Imaging is committed to providing the professional cutting-edge imaging, microscopy products ， microfluidic solutions and develops, manufactures and supports microfluidic components and systems for droplet/microsphere and nanoparticle applications.

We focus on…

1. Spatial Imaging mainly focus on super-resolution imaging and Light-Sheet Microscope technologies, and work closely with the inventor of STED and Light-Sheet Microscope technologies, to provide cutting-edge imaging and microscopy products and experimental solutions with the best resolution performance for life science communities.

2. Development & manufacture of microfluidic control systems.

We provide integrated systems, such as smart LNP generator, microdroplet/microsphere generator, microfluidics distribution system, along with standard microfluidic devices including precision pressure controller, flow sensor, sensor reader, microfluidic distribution valve, solenoid valve and controller, etc.

United Scientific Pty Ltd is an innovative company specializing in the development of medical device and lab equipments, providing product solutions for clinical treatment and scientific research, and accelerating the transformation and commercialization of medical enigineering technology. Engagement with different scalable projects will allow United Scientific Pty Ltd to directly integrate cutting-edge research into its strategic operations, maintaining its competitive advantage and accelerating the commercialization of innovative technologies.

TissueGnostics (TG) is a med-tech company based in Vienna, Austria, founded in 2003. Today the company consists of a global network of subsidiaries, offices and partners on all continents. TG provides fully integrated cutting-edge tissue cytometers for (i) whole-slide imaging (brightfield, fluorescence, confocal, multispectral) and (ii) high-end analysis of tissue sections, cultured cells, TMAs, smears etc. Explore TGs solutions for spatial phenotyping, single cell analysis, molecular single cell profiling, deep-learning algorithms, machine-learning based tissue classification and many more.
As of November 2024, more than 3000 scientific studies have been published in more than 800 peer-reviewed journals from research groups in almost 70 countries.
TG has been closely collaborating with academia since its foundation. Among dozens of collaborative R&D projects have been 7 high-profile EU-funded Marie-Curie Innovative Training Networks. The Australian subsidiary was founded in October 2023.

VectorBuilder: Revolutionize Gene Delivery from Research to Therapy

VectorBuilder is specialising in advanced genetic engineering solutions for research and medicine. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

We offer a range of products and services including vector design and cloning, virus packaging (Lentivirus, Adenovirus, AAV, MMLV, MSCV, Baculovirus, VSV, HSV and Rabies virus), library construction, stable cell line generation, IVT mRNA synthesis, recombinant protein production and GMP manufacturing of clinical-grade plasmids, mRNAs and viruses.